Alexza Pharmaceuticals Has A Partner In Big Pharma, Now What? [View article]
Lets expand and say that no patient wants to be injected as well. Just think what health care providers and patients go through when the patient is moving their entire body while the provider tries to put a needle into them. Just watch some of the real life ER shows.
Alexza Pharmaceuticals Has A Partner In Big Pharma, Now What? [View article]
Even though the article by Bio was very well written, traders still need to do their homework. There are many articles that try to move the stock up or down. Even though this article suggest that this stock is a good stock to own, it is extremely informative and does not look to push you into buying. Be careful of articles that are very positive and/or negative. They may have an agenda. This article's agenda is to inform. You already know my opinion from above. I own and I am holding into 2014. This stock is a great buy. Just remember that the next two earnings reports will not show profits. You are looking to make your money on ALXA in 2014. Also as we get closer to the marketing of Adasuve, you will start seeing the stock price move higher. That is normal. You still want to hold into 2014.
Alexza Pharmaceuticals Has A Partner In Big Pharma, Now What? [View article]
You wrote an excellent article. I listened to the call hoping that traders would bring the stock down so I can buy more for my family. Between yesterday and today, I added another 6500 shares to my brother and sons' account. Traders need to look at the future of ALXA. You allowed traders to do their homework and make their decision. My opinion, I am long looking at the 1st qtr. of 2014 to watch this stock go above $10. I have owned TEVA for many years and they do like to buy other pharmas. But now they are partnering with ALXA and that is just as good. Common sense says this stock will double within a year. For those reading my comments, I am fully in with different stocks and have no additional money to buy more for myself but I do own a tremendous amount of ALXA and have no problem holding this stock. Do your research before buying and make sure you are willing to wait. For me, this was an easy pick. Use common sense when trading and keep out the emotions. Again, very good article and hope most people will go back and listen to the call.
Alexza Pharmaceuticals: A Teva Partnership Of Immense Meaning [View article]
Do not be concerned about the author after reading what they wrote. As a trader, it is up to you to now investigate and you decide whether you are a buy or sell on the stock that is being commented on. There are many that comment trying to manipulate the stocks price and I have made my comments regarding that area many times. I use these comments to buy or sell. Since I own ALXA and believe in its' potential, I hope there will be comments that will bring the stock down so I can buy more for my family. Right now, I have all my money into stocks and not looking to sell; so I cannot buy more at this time. Remember, ALXA will not show profits until after the third qtr. since their drug will not be marketed until the third qtr. Again, read comments but do your research. Let the comments drive you to look at the stock but do not let it influence you. You must do the research and decide.
Alexza Pharmaceuticals: A Teva Partnership Of Immense Meaning [View article]
I have commented previously on ALXA. ALXA is definitely undervalued. I own a tremendous amount of shares and plan on holding this stock into first qtr. of 2014. Normally I buy and sell quickly on many of my purchases but ALXA will move over the $10 mark that one analyst stated. Traders need to realize that Adasuve was approved in the US and Europe and other countries outside of those areas will also be using this drug. The Staccato system identified a possible two hundred other drugs that may be able to be used. Yes testing must be done but just look at their potential. And with TEVA partnering with ALXA is tremendous. I have owned TEVA for years and they are the perfect company to partner with. Also TEVA has a habit of buying other companies so that could be in the future but for now, it does not matter; ALXA is a great buy. I thought yesterdays call went very well and analyst asked some excellent questions and ALXA responded appropriately. ALXA is a buy right now. Went back to the $4.78.
Why Alexza Pharmaceuticals Ran 10% In 5 Minutes [View article]
Must have missed the call from the CEO!!!!. Thanks for the update. The agreement probably caused the change. I just saw the low for the day. Cannot believe how many buy opportunities there are for this stock. Curious to see the direction it takes after the call. Even though I have no funds to buy right now, will buy more for my brother and son. The can hold into 2014. Appreciate the update.
Alexza Pharmaceuticals (ALXA) comes off trading halt, now up 52% premarket following the license deal with Teva (TEVA +0.3% premarket). The conference call discussing the matter is underway. [View news story]
As usual the stock reacted and then went down. That is normal. One analyst made a call that ALXA would go to $10 and that was weeks before this announcement.
This is only my opinion but I believe this stock will go higher than $10. I am willing to hold into 2014. I have a tremendous amount of ALXA and could have sold for a profit but I can wait. The stock sitting at $4.90 is a buy but not sure if it will go lower after their call at 5PM today. They have no profits so you may find sellers who will bring the stock down.. Makes no sense for anyone to sell after hearing the news but again it did go down after the FDA approved the drug. I own TEVA for years and they are always looking to buy other companies. This could be their way in. Common sense says this stock has much more room to grow. They are approved in this country and many others. The TEVA agreement only takes in the USA. Countries all over the world will be selling this drug, not only in Europe. If you have money to buy more, wait until after 5PM and if the stock drops, take full advantage. I would sell my AAPL to buy more ALXA but AAPL has a dividend payment and I believe AAPL will also move to over $500 so I am in hold pattern for most of my stocks. I am not an analyst and I do not look to manipulate a stock based on my opinion. I am staying with ALXA with the belief that it will climb to over $10 in 2014. Each trader must look at their goals. Are they long term, short term, etc. My goals, depending on the stock, are both. With the obesity drugs, my goals were short, make quick profits. For me ALXA is different.
Why Alexza Pharmaceuticals Ran 10% In 5 Minutes [View article]
Just the beginning for ALXA. This is in addition to what it will make in other countries. I also own TEVA and they are always looking to take over other pharmas; this is what made them one of the largest.
ALXA will be moving on to testing other drugs using their Staccato system. I am holding ALXA into 2014. That is when they will start showing profits from the sales of Adasuve. Now that TEVA is involved, I can see them, in the future, looking to buy ALXA. I recommend that all listen to their call at 5PM eastern today, May 9.
Alexza Pharmaceuticals (ALXA) comes off trading halt, now up 52% premarket following the license deal with Teva (TEVA +0.3% premarket). The conference call discussing the matter is underway. [View news story]
I have been advising others through these comments not to sell. I am still holding until after they market the drug.
How Management Misled Investors When It Gained Control Of Medical Marijuana, Inc. [View article]
As I said in my comments yesterday, an investor must be patient and listen to all views and make your decision based on your research. You now have another place to look. MJNA came out with a very informative and long statement. My recommendation is you read and then make your decision. As I said yesterday, I was holding until I could find more info on the stock. A company that may be involved in unethical practices most likely would not come out with a statement. At this time I have no intention of selling my position.
How Management Misled Investors When It Gained Control Of Medical Marijuana, Inc. [View article]
I do not allow a few articles decide whether I buy or sell a stock. If I did, I would have sold Apple. Watching the analyst downgrade did not sway my opinion of Apple. During that time, they increased their dividend and announced a major buyback. That does not even account for what products they will be releasing in the 4th qtr. I will watch Apple hit $500 and probably will sell. Regarding your article, everything could be true and I read others who are pushing other MARIJUANA companies. Traders must be patient and not be quick to trade. I have no problem holding my shares. With 33 mil shares being traded, I believe the stock will move higher. The good part for me is I sold at .40, took profit and bought again at .20.
How Management Misled Investors When It Gained Control Of Medical Marijuana, Inc. [View article]
I am use to reading about people trying to bring down stocks so they could buy more as it dives down. Not saying this is true with this article. Penny stocks are speculative and if you can afford to take a loss on a stock that is so low, I would wait before selling. I am holding my shares until I can find additional info. If all of this is true, I will use this to reduce my gains. If not true, then I will make money. I will wait.
I am looking for those that believe this stock will move higher. I have always commented about people trying to bring down a stock so they can buy more and proved why a particular stock would move higher; those comments have been based on my knowledge of those stocks. Even though I own MJNA my knowledge of what is going on with MJNA is very limited. For those that believe what others are saying is not true, give me evidence on why you believe this stock will move higher.
Alexza Pharmaceuticals (ALXA +4%) gives back a little but remains firmly in the green following a +7% run-up during the pre-open session on an earlier upgrade from Piper Jaffray to Overweight. Piper notes that it's channel checks with ER physicians, psychiatrists, and opinion leaders was even more encouraging than it expected on both the near and longer-term market potential for Adasuve versus previous projections. Additionally, it's clinical attributes bode well for a value-added partnership being signed soon to enable effective launch in Q3. [View news story]
ALXA is an excellent long stock. I own the stock and I am long. If you look at the potential not only of their new drug but the potential of many new drugs as a result of Staccato, ALXA will move to possibly $20 in 2014. I currently have a sell order in at $15 for some of my stock. I have no problem being long on this stock. My normal trading pattern is to buy and sell and make the quick profits as I did with the obesity drugs. But ALXA is different. I recommend that all read about this company and listen to their last quarterly results; not only read but listen to the meeting they held. I only recommend to others what I do.
Alexza Pharmaceuticals (ALXA) is trading higher before the bell after Piper Jaffray upgrades the stock to Overweight from Neutral. Shares +7.3% premarket. [View news story]
I own ALXA and I am long on the stock. Stock is still a good buy. This stock will move much higher when they market their drug in the third qtr. Just be patient.
Alexza Pharmaceuticals Has A Partner In Big Pharma, Now What? [View article]
Alexza Pharmaceuticals Has A Partner In Big Pharma, Now What? [View article]
There are many articles that try to move the stock up or down. Even though this article suggest that this stock is a good stock to own, it is extremely informative and does not look to push you into buying.
Be careful of articles that are very positive and/or negative. They may have an agenda. This article's agenda is to inform.
You already know my opinion from above. I own and I am holding into 2014. This stock is a great buy. Just remember that the next two earnings reports will not show profits. You are looking to make your money on ALXA in 2014. Also as we get closer to the marketing of Adasuve, you will start seeing the stock price move higher. That is normal. You still want to hold into 2014.
Alexza Pharmaceuticals Has A Partner In Big Pharma, Now What? [View article]
Traders need to look at the future of ALXA. You allowed traders to do their homework and make their decision.
My opinion, I am long looking at the 1st qtr. of 2014 to watch this stock go above $10.
I have owned TEVA for many years and they do like to buy other pharmas. But now they are partnering with ALXA and that is just as good. Common sense says this stock will double within a year.
For those reading my comments, I am fully in with different stocks and have no additional money to buy more for myself but I do own a tremendous amount of ALXA and have no problem holding this stock. Do your research before buying and make sure you are willing to wait. For me, this was an easy pick. Use common sense when trading and keep out the emotions.
Again, very good article and hope most people will go back and listen to the call.
Alexza Pharmaceuticals: A Teva Partnership Of Immense Meaning [View article]
There are many that comment trying to manipulate the stocks price and I have made my comments regarding that area many times.
I use these comments to buy or sell. Since I own ALXA and believe in its' potential, I hope there will be comments that will bring the stock down so I can buy more for my family. Right now, I have all my money into stocks and not looking to sell; so I cannot buy more at this time. Remember, ALXA will not show profits until after the third qtr. since their drug will not be marketed until the third qtr.
Again, read comments but do your research. Let the comments drive you to look at the stock but do not let it influence you. You must do the research and decide.
Alexza Pharmaceuticals: A Teva Partnership Of Immense Meaning [View article]
Traders need to realize that Adasuve was approved in the US and Europe and other countries outside of those areas will also be using this drug. The Staccato system identified a possible two hundred other drugs that may be able to be used. Yes testing must be done but just look at their potential.
And with TEVA partnering with ALXA is tremendous. I have owned TEVA for years and they are the perfect company to partner with. Also TEVA has a habit of buying other companies so that could be in the future but for now, it does not matter; ALXA is a great buy.
I thought yesterdays call went very well and analyst asked some excellent questions and ALXA responded appropriately. ALXA is a buy right now. Went back to the $4.78.
Why Alexza Pharmaceuticals Ran 10% In 5 Minutes [View article]
Must have missed the call from the CEO!!!!. Thanks for the update. The agreement probably caused the change.
I just saw the low for the day. Cannot believe how many buy opportunities there are for this stock.
Curious to see the direction it takes after the call. Even though I have no funds to buy right now, will buy more for my brother and son. The can hold into 2014.
Appreciate the update.
Alexza Pharmaceuticals (ALXA) comes off trading halt, now up 52% premarket following the license deal with Teva (TEVA +0.3% premarket). The conference call discussing the matter is underway. [View news story]
One analyst made a call that ALXA would go to $10 and that was weeks before this announcement.
This is only my opinion but I believe this stock will go higher than $10. I am willing to hold into 2014.
I have a tremendous amount of ALXA and could have sold for a profit but I can wait. The stock sitting at $4.90 is a buy but not sure if it will go lower after their call at 5PM today. They have no profits so you may find sellers who will bring the stock down.. Makes no sense for anyone to sell after hearing the news but again it did go down after the FDA approved the drug.
I own TEVA for years and they are always looking to buy other companies. This could be their way in.
Common sense says this stock has much more room to grow. They are approved in this country and many others. The TEVA agreement only takes in the USA. Countries all over the world will be selling this drug, not only in Europe.
If you have money to buy more, wait until after 5PM and if the stock drops, take full advantage. I would sell my AAPL to buy more ALXA but AAPL has a dividend payment and I believe AAPL will also move to over $500 so I am in hold pattern for most of my stocks.
I am not an analyst and I do not look to manipulate a stock based on my opinion. I am staying with ALXA with the belief that it will climb to over $10 in 2014.
Each trader must look at their goals. Are they long term, short term, etc. My goals, depending on the stock, are both.
With the obesity drugs, my goals were short, make quick profits. For me ALXA is different.
Why Alexza Pharmaceuticals Ran 10% In 5 Minutes [View article]
I also own TEVA and they are always looking to take over other pharmas; this is what made them one of the largest.
ALXA will be moving on to testing other drugs using their Staccato system.
I am holding ALXA into 2014. That is when they will start showing profits from the sales of Adasuve.
Now that TEVA is involved, I can see them, in the future, looking to buy ALXA. I recommend that all listen to their call at 5PM eastern today, May 9.
Alexza Pharmaceuticals (ALXA) comes off trading halt, now up 52% premarket following the license deal with Teva (TEVA +0.3% premarket). The conference call discussing the matter is underway. [View news story]
How Management Misled Investors When It Gained Control Of Medical Marijuana, Inc. [View article]
You now have another place to look. MJNA came out with a very informative and long statement. My recommendation is you read and then make your decision. As I said yesterday, I was holding until I could find more info on the stock.
A company that may be involved in unethical practices most likely would not come out with a statement. At this time I have no intention of selling my position.
How Management Misled Investors When It Gained Control Of Medical Marijuana, Inc. [View article]
Regarding your article, everything could be true and I read others who are pushing other MARIJUANA companies. Traders must be patient and not be quick to trade.
I have no problem holding my shares. With 33 mil shares being traded, I believe the stock will move higher. The good part for me is I sold at .40, took profit and bought again at .20.
How Management Misled Investors When It Gained Control Of Medical Marijuana, Inc. [View article]
Not saying this is true with this article. Penny stocks are speculative and if you can afford to take a loss on a stock that is so low, I would wait before selling.
I am holding my shares until I can find additional info. If all of this is true, I will use this to reduce my gains. If not true, then I will make money. I will wait.
Medical Marijuana: Be Careful [View article]
For those that believe what others are saying is not true, give me evidence on why you believe this stock will move higher.
Alexza Pharmaceuticals (ALXA +4%) gives back a little but remains firmly in the green following a +7% run-up during the pre-open session on an earlier upgrade from Piper Jaffray to Overweight. Piper notes that it's channel checks with ER physicians, psychiatrists, and opinion leaders was even more encouraging than it expected on both the near and longer-term market potential for Adasuve versus previous projections. Additionally, it's clinical attributes bode well for a value-added partnership being signed soon to enable effective launch in Q3. [View news story]
My normal trading pattern is to buy and sell and make the quick profits as I did with the obesity drugs. But ALXA is different. I recommend that all read about this company and listen to their last quarterly results; not only read but listen to the meeting they held. I only recommend to others what I do.
Alexza Pharmaceuticals (ALXA) is trading higher before the bell after Piper Jaffray upgrades the stock to Overweight from Neutral. Shares +7.3% premarket. [View news story]